BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martin LK, Hollaus A, Stahuber A, Hübener C, Fraccaroli A, Tischer J, Schub A, Moosmann A. Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B. PLoS Pathog 2018;14:e1006991. [PMID: 29698478 DOI: 10.1371/journal.ppat.1006991] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Sausen DG, Reed KM, Bhutta MS, Gallo ES, Borenstein R. Evasion of the Host Immune Response by Betaherpesviruses. Int J Mol Sci 2021;22:7503. [PMID: 34299120 DOI: 10.3390/ijms22147503] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
2 Eren OE, Tonon M, Schöberl F, Gießen-Jung C, Moosmann A, Hollaus A, Muenchhoff M, Dimitriadis K. Coincidental SARS-CoV-2 infection and mRNA vaccination: a case report addressing the most important clinical questions. Infection 2021;49:785-8. [PMID: 33963523 DOI: 10.1007/s15010-021-01613-w] [Reference Citation Analysis]
3 Annaloro C, Serpenti F, Saporiti G, Galassi G, Cavallaro F, Grifoni F, Goldaniga M, Baldini L, Onida F. Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications. Front Immunol 2020;11:569381. [PMID: 33552044 DOI: 10.3389/fimmu.2020.569381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
4 Hanson DJ, Tsvetkova O, Rerolle GF, Greninger AL, Sette A, Jing L, Campbell VL, Koelle DM. Genome-Wide Approach to the CD4 T-Cell Response to Human Herpesvirus 6B. J Virol 2019;93:e00321-19. [PMID: 31043533 DOI: 10.1128/JVI.00321-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Fastenackels S, Bayard C, Larsen M, Magnier P, Bonnafous P, Seddiki N, Appay V, Gautheret-Dejean A, Sauce D. Phenotypic and Functional Differences between Human Herpesvirus 6- and Human Cytomegalovirus-Specific T Cells. J Virol 2019;93:e02321-18. [PMID: 30996090 DOI: 10.1128/JVI.02321-18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Becerra-Artiles A, Cruz J, Leszyk JD, Sidney J, Sette A, Shaffer SA, Stern LJ. Naturally processed HLA-DR3-restricted HHV-6B peptides are recognized broadly with polyfunctional and cytotoxic CD4 T-cell responses. Eur J Immunol 2019;49:1167-85. [PMID: 31020640 DOI: 10.1002/eji.201948126] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
7 Montoro J, Piñana JL, Sanz J, Guerreiro M. T lymphocytes as therapeutic arsenal for patients with hematological malignancies. Current Opinion in Oncology 2018;30:425-34. [DOI: 10.1097/cco.0000000000000481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Hanson DJ, Hill JA, Koelle DM. Advances in the Characterization of the T-Cell Response to Human Herpesvirus-6. Front Immunol 2018;9:1454. [PMID: 29988505 DOI: 10.3389/fimmu.2018.01454] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]